BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15981227)

  • 1. Venous thromboembolism prevention in the acutely ill medical patient: a review of the literature and focus on special patient populations.
    Pendleton R; Wheeler M; Rodgers G
    Am J Hematol; 2005 Jul; 79(3):229-37. PubMed ID: 15981227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
    Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG;
    Arch Intern Med; 2004 May; 164(9):963-8. PubMed ID: 15136304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
    Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing venous thromboembolism in medical patients.
    Leizorovicz A; Mismetti P
    Circulation; 2004 Dec; 110(24 Suppl 1):IV13-9. PubMed ID: 15598642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism prevention in acutely ill nonsurgical patients.
    Brophy DF; Dougherty JA; Garrelts JC; Parish RC; Rivey MP; Stumpf JL; Taylor CT; Mathis AS
    Ann Pharmacother; 2005; 39(7-8):1318-24. PubMed ID: 15941823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for venous thromboembolism.
    Anderson FA; Spencer FA
    Circulation; 2003 Jun; 107(23 Suppl 1):I9-16. PubMed ID: 12814980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
    Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
    Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolic prophylaxis in hospitalized medical patients.
    Stark JE; Kilzer WJ
    Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
    Turpie AG
    J Thromb Haemost; 2007 Jan; 5(1):5-11. PubMed ID: 17059417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
    Le Sage S; McGee M; Emed JD
    J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of venous thromboembolic risk in acutely ill medical patients immobilized at home: the AT-HOME Study.
    Haas SK; Hach-Wunderle V; Mader FH; Ruster K; Paar WD
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):7-13. PubMed ID: 17164492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of venous thromboembolism in hospitalized medical patients.
    Spyropoulos AC
    Curr Opin Pulm Med; 2010 Sep; 16(5):419-25. PubMed ID: 20592598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
    Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
    Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Up-to-date medical care for perioperative venous thromboembolism in Japan--standardization of care for perioperative venous thromboembolism in Japan: preface].
    Seo N
    Masui; 2007 Jul; 56(7):758-9. PubMed ID: 17633834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in Thai children.
    Sirachainan N; Chuansumrit A; Angchaisuksiri P; Pakakasama S; Hongeng S; Kadegasem P
    Pediatr Hematol Oncol; 2007 Jun; 24(4):245-56. PubMed ID: 17613867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing venous thromboembolism in acute medical patients.
    Elis A; Ellis MH
    QJM; 2004 Dec; 97(12):797-801. PubMed ID: 15569811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.